Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines



   cerebrotendinous xanthomatosis
  

Disease ID 85
Disease cerebrotendinous xanthomatosis
Definition
An autosomal recessive lipid storage disorder due to mutation of the gene CYP27A1 encoding a CHOLESTANETRIOL 26-MONOOXYGENASE. It is characterized by large deposits of CHOLESTEROL and CHOLESTANOL in various tissues resulting in xanthomatous swelling of tendons, early CATARACT, and progressive neurological symptoms.
Synonym
bogaert-scherer-epstein disease, van
cerebral cholesterinoses
cerebral cholesterinosis
cerebrotendinous cholesterinosis
cerebrotendinous xanthomatoses
cholestanol storage disease
cholestanol storage disease (disorder)
cholestanolosis
ctx - cerebrotendinous xanthomatosis
disease, van bogaert-scherer-epstein
van bogaert scherer epstein dis
van bogaert scherer epstein disease
van bogaert-scherer-epstein disease
van bogaert-scherer-epstein syndrome
von bogaert disease
xanthomatoses, cerebrotendinous
xanthomatosis, cerebrotendinous
xanthomatosis, cerebrotendinous [disease/finding]
Orphanet
OMIM
DOID
UMLS
C0238052
MeSH
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:8)
C0155626  |  acute myocardial infarction  |  1
C0152025  |  polyneuropathy  |  1
C0013421  |  dystonia  |  1
C0086543  |  cataract  |  1
C0027051  |  myocardial infarct  |  1
C0014544  |  epilepsy  |  1
C0272286  |  immune thrombocytopenia  |  1
C0027051  |  myocardial infarction  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:1)
CYP27A1  |  1593  |  CLINVAR;CTD_human;UNIPROT;ORPHANET;GHR
Inferring Gene(Waiting for update.)
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:73)
1595  |  CYP51A1  |  DISEASES
7414  |  VCL  |  DISEASES
1414  |  CRYBB1  |  DISEASES
6554  |  SLC10A1  |  DISEASES
1666  |  DECR1  |  DISEASES
59  |  ACTA2  |  DISEASES
1411  |  CRYBA1  |  DISEASES
1410  |  CRYAB  |  DISEASES
1594  |  CYP27B1  |  DISEASES
3670  |  ISL1  |  DISEASES
338  |  APOB  |  DISEASES
335  |  APOA1  |  DISEASES
9409  |  PEX16  |  DISEASES
6718  |  AKR1D1  |  DISEASES
5184  |  PEPD  |  DISEASES
6310  |  ATXN1  |  DISEASES
8431  |  NR0B2  |  DISEASES
79727  |  LIN28A  |  DISEASES
6927  |  HNF1A  |  DISEASES
1593  |  CYP27A1  |  DISEASES
7274  |  TTPA  |  DISEASES
2230  |  FDX1  |  DISEASES
2581  |  GALC  |  DISEASES
3290  |  HSD11B1  |  DISEASES
10858  |  CYP46A1  |  DISEASES
8647  |  ABCB11  |  DISEASES
1356  |  CP  |  DISEASES
2651  |  GCNT2  |  DISEASES
1181  |  CLCN2  |  DISEASES
3073  |  HEXA  |  DISEASES
5428  |  POLG  |  DISEASES
4240  |  MFGE8  |  DISEASES
3156  |  HMGCR  |  DISEASES
1409  |  CRYAA  |  DISEASES
79443  |  FYCO1  |  DISEASES
83592  |  AKR1E2  |  DISEASES
1581  |  CYP7A1  |  DISEASES
2990  |  GUSB  |  DISEASES
8419  |  BFSP2  |  DISEASES
9420  |  CYP7B1  |  DISEASES
10170  |  DHRS9  |  DISEASES
3291  |  HSD11B2  |  DISEASES
1582  |  CYP8B1  |  DISEASES
1555  |  CYP2B6  |  DISEASES
2318  |  FLNC  |  DISEASES
6667  |  SP1  |  DISEASES
55328  |  RNLS  |  DISEASES
8856  |  NR1I2  |  DISEASES
1576  |  CYP3A4  |  DISEASES
347  |  APOD  |  DISEASES
55750  |  AGK  |  DISEASES
337  |  APOA4  |  DISEASES
1969  |  EPHA2  |  DISEASES
56980  |  PRDM10  |  DISEASES
617  |  BCS1L  |  DISEASES
9361  |  LONP1  |  DISEASES
336  |  APOA2  |  DISEASES
1718  |  DHCR24  |  DISEASES
6342  |  SCP2  |  DISEASES
9314  |  KLF4  |  DISEASES
1880  |  GPR183  |  DISEASES
83889  |  WDR87  |  DISEASES
5160  |  PDHA1  |  DISEASES
1130  |  LYST  |  DISEASES
3778  |  KCNMA1  |  DISEASES
10062  |  NR1H3  |  DISEASES
5830  |  PEX5  |  DISEASES
6513  |  SLC2A1  |  DISEASES
629  |  CFB  |  DISEASES
4700  |  NDUFA6  |  DISEASES
2317  |  FLNB  |  DISEASES
9971  |  NR1H4  |  DISEASES
4566  |  MT-TK  |  DISEASES
Locus
Symbol | Locus(Total Locus:1)
CYP27A1  |  2q35
Disease ID 85
Disease cerebrotendinous xanthomatosis
Integrated Phenotype
HPO | Name(Total Integrated Phenotypes:54)
HP:0001332  |  Dystonia
HP:0001373  |  Joint dislocation
HP:0000738  |  Hallucinations
HP:0000787  |  Nephrolithiasis
HP:0002514  |  Cerebral calcification
HP:0001324  |  Muscle weakness
HP:0001337  |  Tremor
HP:0000708  |  Behavioral abnormality
HP:0002014  |  Diarrhea
HP:0001396  |  Cholestasis
HP:0003107  |  Abnormality of cholesterol metabolism
HP:0009830  |  Peripheral neuropathy
HP:0001114  |  Fatty deposits on eyelids
HP:0001114  |  Xanthelasma
HP:0002353  |  EEG abnormality
HP:0001272  |  Cerebellar atrophy
HP:0001251  |  Ataxia
HP:0002621  |  Atherosclerosis
HP:0000504  |  Abnormality of vision
HP:0001249  |  Mental retardation
HP:0010874  |  Tendon xanthomatosis
HP:0001081  |  Gallstones
HP:0001250  |  Seizures
HP:0000478  |  Abnormality of the eye
HP:0010845  |  EEG: generalised slow activity
HP:0001257  |  Spasticity
HP:0002059  |  Degeneration of cerebrum
HP:0007256  |  Abnormal pyramidal signs
HP:0100291  |  Abnormality of central somatosensory evoked potentials
HP:0002376  |  Developmental regression
HP:0007024  |  Pseudobulbar palsy
HP:0000939  |  Osteoporosis
HP:0000726  |  Dementia
HP:0000746  |  Delusions
HP:0100321  |  Abnormality of the dentate nucleus
HP:0000716  |  Depression
HP:0003124  |  Hypercholesterolemia
HP:0002518  |  Abnormality of the periventricular white matter
HP:0002167  |  Neurological speech impairment
HP:0000991  |  Xanthomatosis
HP:0002024  |  Malabsorption
HP:0002071  |  Abnormality of extrapyramidal motor function
HP:0003482  |  EMG: axonal abnormality
HP:0000518  |  Cataract
HP:0009830  |  Peripheral neuritis
HP:0001347  |  Hyperreflexia
HP:0001658  |  Myocardial infarction
HP:0000543  |  Pale optic disc
HP:0001249  |  Intellectual disability
HP:0001681  |  Angina pectoris
HP:0001387  |  Joint stiffness
HP:0000738  |  Sensory hallucination
HP:0002093  |  progressive respiratory failure
HP:0001336  |  Myoclonus
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:8)
HP:0001300  |  Parkinsonism  |  1
HP:0002459  |  Dysautonomia  |  1
HP:0100561  |  Spinal cord lesion  |  1
HP:0001271  |  Polyneuropathy  |  1
HP:0001332  |  Dystonia  |  1
HP:0001658  |  Myocardial infarction  |  1
HP:0001973  |  Autoimmune thrombocytopenia  |  1
HP:0000518  |  Cataract  |  1
Disease ID 85
Disease cerebrotendinous xanthomatosis
Manually Symptom
UMLS  | Name(Total Manually Symptoms:11)
C2678504  |  osteoporosis
C1963826  |  mitochondrial enzyme deficiency
C1956346  |  coronary artery disease
C0302314  |  xanthomata
C0302314  |  xanthomas
C0270922  |  demyelinating peripheral neuropathy
C0242422  |  parkinsonism
C0086437  |  joint hypermobility
C0031117  |  peripheral neuropathy
C0027709  |  nephrocalcinosis
C0010068  |  coronary heart disease
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:2)
C0302314  |  xanthomas  |  1
C0242422  |  parkinsonism  |  1
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:52)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs121908096NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218814186CA,T
rs121908097NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218814702GA
rs121908098NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218814701CT
rs121908099NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218814409GA
rs12190809991869051593CYP27A1umls:C0238052UNIPROTNovel homozygous and compound heterozygous mutations of sterol 27-hydroxylase gene (CYP27) cause cerebrotendinous xanthomatosis in three Japanese patients from two unrelated families.0.5172570571997CYP27A12218814409GA
rs121908102NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218813095CT
rs200553205NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218813096GA,C
rs200883871NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218814696GC
rs201114717NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218809700CG,T
rs201346271NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218812421GC
rs376230356NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218809701GA
rs397515353NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218812923GA
rs397515354NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218812750GA,C
rs397515355NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218814459GA
rs397515356NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218813023TGGCC-
rs41272687NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218814154CT
rs573951598NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218814408CT
rs587778777NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218814188GA
rs587778778NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218814187GA
rs587778779NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218814379GT
rs587778780NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218814397CG
rs587778781NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218814404CG
rs587778782NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218814417GT
rs587778783NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218814433TA
rs587778784NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218814463GT
rs587778785NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218814544GA
rs587778787NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218814683CT
rs587778790NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218809626C-
rs587778793NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218809676C-
rs587778794NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218809690GTACCCA-
rs587778795NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218809754GA
rs587778796NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218809756GT
rs587778797NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218809768GA
rs587778800NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218812358GT
rs587778802NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218782187-C
rs587778804NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218812551GT
rs587778807NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218782255G-
rs587778808NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218812657CA
rs587778810NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218812684GA
rs587778812NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218812724T-
rs587778815NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218812942A-
rs587778818NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218809731GA
rs72551312NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218809730CT
rs72551313NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218809755GA
rs72551314NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218812250CT
rs72551315NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218812596CT
rs72551316NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218812650CT
rs72551317NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218812681AG
rs72551318NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218812713CG,T
rs72551319NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218812929AT
rs72551320NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218814064AG
rs72551322NA1593CYP27A1umls:C0238052CLINVARNA0.517257057NACYP27A12218814716CA,G,T
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:1)
HP ID HP Name MP ID MP Name Annotation
HP:0001300ParkinsonismMP:0005402abnormal action potential;HP:0001677Coronary artery disease
Chemical(Total Drugs:0)
(Waiting for update.)
FDA approved drug and dosage information(Total Drugs:0)
(Waiting for update.)
FDA labeling changes(Total Drugs:0)
(Waiting for update.)